When is biologic therapy recommended for psoriasis?

The decision is based on more than the visible area of skin. Your clinician considers plaque thickness, itch, soreness, scalp or genital involvement, hand or foot disability, sleep and work disruption, and how psoriasis responds to creams, light treatment, or tablets. Joint pain, swelling, or prolonged morning stiffness may suggest psoriatic arthritis and should be reported. A biologic acts on selected immune pathways and requires a safety review, including infection history, other medicines, and relevant screening.

List treatments you have tried, how long you used them, and why they were stopped. Take photographs during flares and describe effects on sleep, clothing, movement, and mood. Mention recurrent infections, tuberculosis exposure, liver disease, bowel symptoms, pregnancy plans, and vaccinations. Ask how the medicine is given, what monitoring is needed, when improvement is assessed, and what to do after a missed dose.

Get prompt care for widespread rapidly worsening redness, extensive peeling, fever, chills, severe weakness, or painful pustules. Seek urgent assessment for a hot swollen joint or sudden inability to use a limb. During biologic treatment, report persistent fever, breathing symptoms, signs of infection, or facial swelling promptly.

Ask whether your skin pattern or joint symptoms make systemic treatment appropriate, which alternatives are available, and how safety will be checked. Discuss whether topical treatment should continue, how response and relapse will be handled, and which warning symptoms should interrupt treatment.